Fresenius Medical Care
All
Newsflash
Article
-
Fresenius Medical Care (FMS) shares fell 8.0% to €41.285, as investors were concerned about the continued weakness in U.S. patient treatment volumes, despite better-than-expected second-quarter earnings.
The dialysis service provider reported Q2 operating income (excluding special items) of €569 million, a 23% year-over-year increase, surpassing the market consensus of €515 million. Revenue reached €4
-
Fresenius Medical Care (FMS) shares fell 8.0% to €41.285, as investors were concerned about the continued weakness in U.S. patient treatment volumes, despite better-than-expected second-quarter earnings.
The dialysis service provider reported Q2 operating income (excluding special items) of €569 million, a 23% year-over-year increase, surpassing the market consensus of €515 million. Revenue reached €4
- No data
Fresenius Medical Care
Svmuu provides news and information related to Fresenius Medical Care, as well as real-time data on Fresenius Medical Care. We provide in-depth analysis and interpretation of the latest Fresenius Medical Care developments, helping investors stay informed about Fresenius Medical Care policy updates. Svmuu is your essential tool for keeping up with the latest Fresenius Medical Care trends! Here, we’ll join you in keeping a close eye on Fresenius Medical Care news and use a clear macro perspective to make sense of the uncertain future of crypto.
24H Trending
-
1
Court documents reveal: OpenAI and Microsoft executives admit AI poses a substantial threat to journalism, with a Microsoft executive calling it potentially "the largest theft of labor in human history."
-
2
Goldman Sachs Analysis: Historically, US stock energy and technology sectors outperform after Federal Reserve rate hikes, while real estate lags; the pace of rate hikes is key to US stock performance.
-
3
ArbDoge AI (AIDOGE) Token: Latest Developments, Risks, and Long-Term Holding Considerations
-
4
The U.S. House of Representatives is in recess, and AI regulatory legislation will be postponed until after the midterm elections.
-
5
BABYSHIBA Coin Analysis: Memecoin Positioning, Multi-chain Status, and Trading Activity Review
-
6
CoreWeave stock down 32% since joining Nasdaq 100, executives sold over $600M in shares
-
7
The New York Times reported that OpenAI employees were aware that AI posed an "existential threat" to publishers.
-
8
EZDex (EZX) Token Status Analysis: Market Activity and Historical Overview
-
9
KEX Coin Multiple Meanings Explained: The Status and Prospects of KIRA Network (KEX) and Other Entities with the Same Name
-
10
TRUMP'S HAT and MAGA Tokens: Issuance, Circulation, and Market Overview Analysis
Markets Today
Recommended Reading





